Abstract 410P
Background
Cell-free DNA (cfDNA) fragmentation patterns hold immense potential for early cancer detection. However, the lack of systematic comparison among these patterns has impeded their broader research and practical implementation.
Methods
Here, we collected over 1,382 plasma cfDNA sequencing samples from diverse sources, covering eight cancer types including breast cancer, cholangiocarcinoma, colorectal cancer, gastric cancer, lung cancer, ovarian cancer, pancreatic cancer, and liver cancer. Considering that cfDNA within open chromatin regions is more susceptible to fragmentation, we leveraged ten fragmentation patterns within open chromatin regions as features and employed machine learning techniques to evaluate their performance. The considered fragmentation patterns included Windowed Protection Score, Preferred end coordinates, Coverage, Orientation-aware Cell-free Fragmentation, DNA Evaluation of Fragments for early Interception, Fragment Size Ratio, Fragment Size Distribution, End Motif preferences, Promoter Fragmentation Entropy, and Integrated Fragmentation Score.
Results
All fragmentation patterns demonstrated discernible classification capabilities, and the category of fragmentation patterns incorporating both fragment length and coverage information exhibited robust predictive capacities. The ensemble model integrating all these fragmentation patterns further improved performance in cancer detection and tissue-of-origin analysis. Biologically, crucial features of the model captured critical regulatory regions involved in cancer pathogenesis.
Conclusions
A comprehensive machine-learning-based evaluation of ten major cfDNA fragmentation patterns for early cancer detection was performed. Enhanced performance in cancer diagnosis and tissue-of-origin estimation was achieved, through integration of these fragmentation patterns in an ensemble model with biological interpretability.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
26P - Subcutaneous trastuzumab versus intravenous trastuzumab for treatment of patients with HER2-positive breast cancer: A time, motion and cost-benefit assessment in a day care oncology unit in China
Presenter: Bei Sun
Session: Poster Display
Resources:
Abstract
27P - The biological characteristics of HER2-low in TNBC using mRNA profiling and molecular subtypes
Presenter: Asako Tsuruga
Session: Poster Display
Resources:
Abstract
28P - One-week ultra-hypofractionated partial breast RT in early breast cancer: 3DCRT vs IMRT
Presenter: Nurilla Zaynutdinov
Session: Poster Display
Resources:
Abstract
30P - Stereotactic body radiotherapy using cyberknife versus interstitial brachytherapy in accelerated partial breast irradiation on left-sided breast: A comparison of preliminary clinical result and dosimetric characteristics
Presenter: Ting-Na Wei
Session: Poster Display
Resources:
Abstract
31P - Prognostic implication of breast edema on preoperative breast MRI in breast cancer
Presenter: Ki-tae Hwang
Session: Poster Display
Resources:
Abstract
32P - Efficacy of olanzapine in the prophylaxis of delayed chemotherapy-induced nausea and vomiting in breast cancer patients receiving dose-dense AC with a steroid-sparing regimen: A single-center pilot study
Presenter: Manami Tada
Session: Poster Display
Resources:
Abstract
34P - Social support as the mediator of the association between unmet needs and happiness among women with early breast cancer
Presenter: Nithiya Sinarajoo
Session: Poster Display
Resources:
Abstract
35P - Prospective study assessing the efficacy and safety of a scalp cooling device for the prevention of alopecia in breast cancer patients undergoing (neo)adjuvant chemotherapy
Presenter: Winnie Yeo
Session: Poster Display
Resources:
Abstract
37P - To excise or not to excise: Preventive management of early breast cancer in atypical ductal hyperplasia patients
Presenter: Clarisse Hing
Session: Poster Display
Resources:
Abstract
38P - Exploring prognostic factors in patients achieving PCR after neoadjuvant therapy for triple-negative breast cancer: A retrospective study based on SEER data
Presenter: Lv Wenjie
Session: Poster Display
Resources:
Abstract